Reported 8 days ago
Health stocks fell sharply after President-elect Donald Trump nominated vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Analysts warn that Kennedy's controversial views on vaccines could adversely impact the biotechnology sector, leading to decreased demand and potential public health risks. Major pharmaceutical companies, especially those involved in vaccines like Moderna and Pfizer, faced significant stock declines, while biopharma and medical technology sectors also saw losses amidst uncertainty regarding potential regulatory changes.
Source: YAHOO